Drug Shortage Report for OMNIPAQUE 240

Last updated on 2025-02-14 History
Report ID 248506
Drug Identification Number 02172739
Brand name OMNIPAQUE 240
Common or Proper name iohexol injection USP
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) IOHEXOL
Strength(s) 518MG
Dosage form(s) SOLUTION
Route of administration RECTAL ORAL INTRA-ARTICULAR INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL
Packaging size 100 mL
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Other (Please describe in comments)
Anticipated start date 2025-02-13
Actual start date 2025-02-12
Estimated end date 2025-03-03
Actual end date
Shortage status Actual shortage
Updated date 2025-02-14
Company comments Reason for shortage: production release delay. A substitute of same concentration but at a different volume will be offered as an alternative.
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@gehealthcare.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2025-01-24 English Compare
v2 2025-01-24 English Compare
v3 2025-01-24 English Compare
v4 2025-01-24 French Compare
v5 2025-01-24 French Compare
v6 2025-02-04 English Compare
v7 2025-02-05 English Compare
v8 2025-02-05 French Compare
v9 2025-02-07 English Compare
v10 2025-02-07 French Compare
v11 2025-02-11 English Compare
v12 2025-02-11 French Compare
v13 2025-02-12 English Compare
v14 2025-02-12 French Compare
v15 2025-02-13 English Compare
v16 2025-02-14 English Compare
v17 2025-02-14 French Compare

Showing 1 to 17 of 17